Cargando…

Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis

Objective: To evaluate the efficacy and safety of different doses of sildenafil for persistent pulmonary hypertension of the newborn (PPHN) with Bayesian random effects network meta-analysis. Methods: We searched Chinese and English databases for randomized controlled trials (RCTs) concerning silden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Linli, Wang, Chunxia, Zhou, Yulu, Sun, Wei, Wang, Chunjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497971/ https://www.ncbi.nlm.nih.gov/pubmed/34630080 http://dx.doi.org/10.3389/fphar.2021.697287

Ejemplares similares

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Pharmacokinetics of single dose sildenafil orally administered in canine models of chronic embolic pulmonary hypertension
por: AKABANE, Ryota, et al.
Publicado: (2020)

Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn
por: Kang, Lili, et al.
Publicado: (2022)

Black lung persistent pulmonary hypertension of the newborn: Saudi experience with sildenafil and nitric oxide
por: Alnemri, AbdulRahman M.
Publicado: (2017)

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension
por: Li, Xinmei, et al.
Publicado: (2020)

Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility
por: Adnan, Mudasser, et al.
Publicado: (2021)

Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn
por: Wedgwood, Stephen, et al.
Publicado: (2015)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
por: Wei, Enhuan, et al.
Publicado: (2023)

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
por: Shu, Tingting, et al.
Publicado: (2021)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
por: Beghetti, Maurice, et al.
Publicado: (2017)

Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report
por: Daniyan, Olapeju, et al.
Publicado: (2022)

Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure
por: Desai, Kinjal, et al.
Publicado: (2023)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Persistent pulmonary hypertension of the newborn
por: Sharma, Vinay, et al.
Publicado: (2015)

Persistent Pulmonary Hypertension in the Newborn
por: Mathew, Bobby, et al.
Publicado: (2017)

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
por: van der Graaf, Marisa, et al.
Publicado: (2019)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
por: Zhang, Ruihua, et al.
Publicado: (2022)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
por: Dodgen, Andrew L, et al.
Publicado: (2015)

Case Report: Persistent Pulmonary Hypertension of the Newborn and Narrowing of the Ductus Arteriosus After Topical Use of Non-Steroidal Anti-Inflammatory During Pregnancy
por: Le Duc, Kévin, et al.
Publicado: (2021)

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
por: Verlinden, Nathan J., et al.
Publicado: (2020)

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia
por: Macente, Julia, et al.
Publicado: (2023)

Lower Doses of Bosentan in Combination With Sildenafil Might be Beneficial in Pulmonary Arterial Hypertension
por: Amin, Ahmad, et al.
Publicado: (2015)

Efficacy and Safety of Iclaprim for the Treatment of Skin Structures and Soft Tissue Infections: A Methodological Framework
por: Wang, Lian, et al.
Publicado: (2022)

A Meta-Analysis of the Risk Factors of Persistent Pulmonary Hypertension in Newborns
por: Zhou, Ran, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

A Pilot Study of Nutritional Status Prior to Bariatric Surgery in South China
por: Sun, Linli, et al.
Publicado: (2021)

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn
por: Roofthooft, M. T. R., et al.
Publicado: (2011)

Risk factors for persistent pulmonary hypertension of the newborn
por: Delaney, Cassidy, et al.
Publicado: (2012)

Altered metabolites in newborns with persistent pulmonary hypertension
por: Steurer, Martina A., et al.
Publicado: (2018)

Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome
por: Wang, Chunjiang, et al.
Publicado: (2022)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Shi, Yinan, et al.
Publicado: (2021)

Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia – a case report
por: Lavie-Nevo, Karen, et al.
Publicado: (2019)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glafs4fdjm6p7ckbhnli480n44